Cumberland Pharmaceuticals price to sales ratio CPIX

Market value divided by revenue over the last twelve months, since 2012.

Today, Oct 23, 2026: 4.1×
10-year median: 1.2×
Against its 10-year history: 100th; percentile: 0 is its lowest day, 100 its highest
10-year range: 0.4× to 4.1×
Peer median: 1.4×

Cumberland Pharmaceuticals' price to sales ratio is 4.1× as of Oct 23, 2026.

That is above its ten-year median of 1.2×, higher than on 100% of days in the last ten years.

Over that time it ranged from 0.4× in Nov 2024 to 4.1× in Oct 2026.

The median for 10 large drugmakers of a similar size is 1.4×.

Price to sales ratio over time

median 1.2×

The dashed line is the 10-year median and the shaded band the middle half of its days.

Open the interactive chart, with overlays and comparisons

Year by year

Year	End of year	Low	High
2026 so far	4.1×	1.0×	4.1×
2025	1.5×	0.7×	2.4×
2024	0.9×	0.4×	0.9×
2023	0.6×	0.5×	1.0×
2022	0.8×	0.7×	1.7×
2021	1.8×	0.9×	2.0×
2020	1.1×	1.1×	1.7×
2019	1.6×	1.5×	2.5×
2018	2.4×	2.0×	2.9×
2017	3.0×	2.8×	3.4×
2016	2.8×	2.1×	2.8×
2015	2.5×	2.5×	3.4×
2014	2.9×	2.2×	2.9×
2013	2.5×	1.6×	2.5×
2012	1.6×	1.6×	2.6×

Against its peers

Companies in Drug Manufacturers - General nearest Cumberland Pharmaceuticals' size, closest first, today.

Company	Price to sales ratio
CPIXCumberland Pharmaceuticals	4.1×
NATRNatures Sunshine Products	0.4×
LFVNLifevantage	0.4×
SPROSpero Therapeutics	1.4×
ATNMActinium Pharmaceuticals	n/m
ARVNArvinas	1.5×
PBYIPuma Biotechnology	2.5×
IRWDIronwood Pharmaceuticals	1.5×
ZVRAZevra Therapeutics	4.3×
CRMDCorMedix	1.3×
COLLCollegium Pharmaceutical	0.9×
Peer median	1.4×

Where Cumberland Pharmaceuticals ranks

#73of 157Large drugmakers with the lowest price to sales ratio

What the price to sales ratio tells you

Market value divided by revenue over the last twelve months. Useful for companies with little or no profit yet, since sales are harder to make negative than earnings.

Ignores margins entirely. A software company at 10× sales with 30% margins can be cheaper than a grocer at 1× sales with 2% margins.

More on Cumberland Pharmaceuticals

Valuation data, not investment advice. Prices as of Oct 23, 2026. Reported figures come from the company's filings with the SEC.